A Clinical Trial of Immunobridging and Lot-to-lot Consistency of COVID-19 Vaccine (Ad5-nCoV) in Different Age Groups.
Clinical trial NCT04916886 · COMPLETED
Trial details
- NCT number
- NCT04916886
- Sponsor
- CanSino Biologics Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-03
- Primary completion
- 2022-07-31
- Enrollment
- 2021
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.